查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613423

Disulfiram市场：依适应症、通路划分 - 全球预测 2025-2030

Disulfiram Market by Indication (Alcoholism Treatment, Co-occurring Disorders), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Disulfiram市场价值为3.7519亿美元，预计2024年将达到3.9275亿美元，复合年增长率为4.81%，预计到2030年将达到5.2163亿美元。

Disulfiram主要用于治疗慢性酒精中毒，透过在摄取酒精时引起不愉快的反应而具有抑制饮酒的作用。这种药物的需求在于它作为综合成瘾治疗工具的作用，帮助患者保持清醒。它的用途主要是在医疗领域，由医疗保健专业人员为患有酒精依赖的患者开处方。最终用途应用范围显着扩展到医疗保健行业，包括医院、復健中心和家庭护理场所。Disulfiram市场的成长受到人们对酒精相关疾病的认识不断提高、全球酒精成瘾盛行率上升以及优先考虑心理健康的社会转变的影响。最近的机会包括在酒精消费量高的新兴市场的潜在扩张以及整合到提供远端医疗和远端患者监护的数位医疗平台。一项策略建议是探索与科技公司的合作关係，开发创新的输送系统，例如植入物和联合治疗，以提高依从性和疗效。

主要市场统计
基准年[2023] 37519万美元
预计年份 [2024] 3.9275亿美元
预测年份 [2030] 52163万美元
复合年增长率（%） 4.81%

然而，由于与Disulfiram使用相关的副作用以及具有不同作用机制的替代疗法的可用性，患者犹豫不决，市场面临限制。这些挑战凸显了对Disulfiram的功效和益处进行持续教育的必要性。潜在的创新领域包括最大限度地减少副作用的客製化给药方案、先进的药物传递系统以及影响药物代谢的遗传因素的研究，以更好地制定个人化治疗计划。此外，探索Disulfiram治疗其他疾病的潜力，例如在初步研究中显示出前景的某些癌症，可能会开拓新的细分市场。市场呈现动态性，主要来自非专利製造商的适度竞争。市场参与者可以透过投资研发来改进配方和给药方法、加强其药物的治疗概况和市场地位来获得优势。

市场动态：揭示快速发展的Disulfiram市场的关键市场洞察

Disulfiram市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地酗酒者人数不断增加
    • 提高患者意识和治疗咨询率
  • 市场限制因素
    • 与使用Disulfiram相关的副作用
  • 市场机会
    • 各国政府为遏制饮酒所做的积极努力
    • 药物传递系统的创新，包括更有效的口服製剂
  • 市场挑战
    • Disulfiram功效问题

波特的五力战略工具驾驭Disulfiram市场

波特的五力架构是了解Disulfiram市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Disulfiram市场的外部影响

外部宏观环境因素对Disulfiram市场表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解Disulfiram市场的竞争状况

对Disulfiram市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵Disulfiram市场供应商的绩效评估

FPNV定位矩阵是评估Disulfiram市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划Disulfiram市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对Disulfiram市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 酒精成瘾在世界呈现上升趋势
      • 提高患者意识和治疗就诊率
    • 抑制因素
      • 与使用Disulfiram相关的副作用
    • 机会
      • 各国政府为遏制饮酒所做的积极努力
      • 药物传递系统的创新，例如更有效的口服製剂
    • 任务
      • 与Disulfiram功效相关的问题
  • 市场区隔分析
    • 适应症：增加Disulfiram在慢性酒精成瘾治疗的使用
    • 分销管道：医疗机构内的医院药房增加Disulfiram的供应
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Disulfiram市场的适应症

  • 酒精成瘾治疗
  • 併发疾病

第七章Disulfiram市场：依分销通路划分

  • 医院药房
  • 网路药房
  • 零售药房

第八章 美洲Disulfiram市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区Disulfiram市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲Disulfiram市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 庆祝康復：SAMHSA 九月药物使用和心理健康倡议的亮点
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Allergan plc
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Lupin Pharmaceuticals, Inc.
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Odyssey pharmaceuticals inc
  • Par pharmaceutical inc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Watson laboratories Inc.
  • Zydus Lifesciences Limited
Product Code: MRR-CD5A9334CF54

The Disulfiram Market was valued at USD 375.19 million in 2023, expected to reach USD 392.75 million in 2024, and is projected to grow at a CAGR of 4.81%, to USD 521.63 million by 2030.

Disulfiram, primarily used for treating chronic alcoholism, acts by deterring consumption through unpleasant reactions when alcohol is ingested. This medication's necessity lies in its role as a tool in comprehensive addiction therapy, helping patients maintain sobriety. The application is predominantly in the medical domain, prescribed by healthcare professionals for individuals struggling with alcohol dependence. The end-use scope largely encompasses the healthcare industry, including hospitals, rehabilitation centers, and home care settings. Market growth for disulfiram is influenced by rising awareness of alcohol-related disorders, increased incidence of alcoholism globally, and a societal shift towards mental health prioritization. Latest opportunities include potential expansion in emerging markets where alcohol consumption is significant, coupled with integration into digital health platforms offering telemedicine and remote patient monitoring. A strategic recommendation is to explore collaborations with technology firms to develop innovative delivery systems such as implantable forms or combination therapies that increase compliance and efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 375.19 million
Estimated Year [2024] USD 392.75 million
Forecast Year [2030] USD 521.63 million
CAGR (%) 4.81%

However, the market faces limitations due to side effects associated with disulfiram use, which can deter patients, and the availability of alternative therapies that offer different mechanisms of action. These challenges emphasize the necessity for ongoing education about disulfiram's efficacy and benefits. Potential areas for innovation include research into tailored dosing regimens that minimize side effects, advanced drug delivery systems, and the study of genetic factors influencing drug metabolism to better personalize treatment plans. Additionally, exploring disulfiram's potential in treating other conditions, such as certain cancers where it has shown promise in preliminary studies, could open new market segments. The market demonstrates a dynamic nature with moderate competition, primarily driven by generic manufacturers. Market players could gain an edge by investing in R&D to improve formulation and delivery methods, strengthening the drug's therapeutic profile and market standing.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Disulfiram Market

The Disulfiram Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing cases of alcohol addiction across the globe
    • Increasing patient awareness and higher treatment-seeking rate
  • Market Restraints
    • Side effects associated with the use of disulfiram
  • Market Opportunities
    • Favorable efforts from the governments to curb the use of alcohol
    • Innovations in drug delivery systems, such as more efficient oral formulations
  • Market Challenges
    • Issues associated with the effectiveness of disulfiram

Porter's Five Forces: A Strategic Tool for Navigating the Disulfiram Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Disulfiram Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Disulfiram Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Disulfiram Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Disulfiram Market

A detailed market share analysis in the Disulfiram Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Disulfiram Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Disulfiram Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Disulfiram Market

A strategic analysis of the Disulfiram Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Disulfiram Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Allergan plc, Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Lupin Pharmaceuticals, Inc., Merck KGaA, Mylan N.V., Novartis AG, Odyssey pharmaceuticals inc, Par pharmaceutical inc, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Watson laboratories Inc., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Disulfiram Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Alcoholism Treatment and Co-occurring Disorders.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing cases of alcohol addiction across the globe
      • 5.1.1.2. Increasing patient awareness and higher treatment-seeking rate
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with the use of disulfiram
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable efforts from the governments to curb the use of alcohol
      • 5.1.3.2. Innovations in drug delivery systems, such as more efficient oral formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the effectiveness of disulfiram
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising usage of disulfiram for the treatment of chronic alcoholism
    • 5.2.2. Distribution Channel: Rising availability of disulfiram in hospital pharmacies which are located within medical facilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Disulfiram Market, by Indication

  • 6.1. Introduction
  • 6.2. Alcoholism Treatment
  • 6.3. Co-occurring Disorders

7. Disulfiram Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Disulfiram Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Disulfiram Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Disulfiram Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Celebrating Recovery: Highlighting SAMHSA's September Initiative on Substance Use and Mental Health
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alkem Laboratories Ltd.
  • 3. Allergan plc
  • 4. Aspen Pharmacare Holdings Limited
  • 5. Aurobindo Pharma Limited
  • 6. Bausch Health Companies Inc.
  • 7. Bayer AG
  • 8. Cipla Inc.
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. Eli Lilly and Company
  • 11. Lupin Pharmaceuticals, Inc.
  • 12. Merck KGaA
  • 13. Mylan N.V.
  • 14. Novartis AG
  • 15. Odyssey pharmaceuticals inc
  • 16. Par pharmaceutical inc
  • 17. Pfizer Inc.
  • 18. Sanofi S.A.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Torrent Pharmaceuticals Ltd.
  • 21. Watson laboratories Inc.
  • 22. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. DISULFIRAM MARKET RESEARCH PROCESS
  • FIGURE 2. DISULFIRAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DISULFIRAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DISULFIRAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DISULFIRAM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DISULFIRAM MARKET DYNAMICS
  • TABLE 7. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOLISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DISULFIRAM MARKET SIZE, BY CO-OCCURRING DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DISULFIRAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DISULFIRAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2023